Jury Selection Begins In High-Stakes Battle Over Stent Patents

Law360, New York (June 13, 2005, 12:00 AM EDT) -- Jury selection begins Monday in the closely watched patent dispute between Johnson & Johnson and Boston Scientific Corp. over the lucrative $5 billion market for drug-coated heart stents.

The trial, scheduled to begin in U.S. District Court for the District of Delaware on June 21, will focus on whether Boston Scientific infringed a Johnson & Johnson patent issued in 1988 for a stent. Another trial to set damages would be held in August if Johnson & Johnson wins.

Johnson & Johnson's Cordis unit is seeking at...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.